KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

LifeMD (LFMD) Operating Expenses (2016 - 2025)

LifeMD (LFMD) has disclosed Operating Expenses for 14 consecutive years, with $9.1 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Operating Expenses rose 196.28% year-over-year to $9.1 million, compared with a TTM value of $174.0 million through Dec 2025, up 13.75%, and an annual FY2025 reading of $174.0 million, up 13.15% over the prior year.
  • Operating Expenses was $9.1 million for Q4 2025 at LifeMD, down from $54.7 million in the prior quarter.
  • Across five years, Operating Expenses topped out at $55.7 million in Q2 2025 and bottomed at $3.1 million in Q4 2024.
  • Average Operating Expenses over 5 years is $37.4 million, with a median of $36.6 million recorded in 2022.
  • The sharpest move saw Operating Expenses soared 471.52% in 2021, then tumbled 92.65% in 2024.
  • Year by year, Operating Expenses stood at $35.5 million in 2021, then fell by 3.07% to $34.4 million in 2022, then increased by 21.07% to $41.7 million in 2023, then crashed by 92.65% to $3.1 million in 2024, then surged by 196.28% to $9.1 million in 2025.
  • Business Quant data shows Operating Expenses for LFMD at $9.1 million in Q4 2025, $54.7 million in Q3 2025, and $55.7 million in Q2 2025.